简体中文
繁體中文
English
Pусский
日本語
ภาษาไทย
Tiếng Việt
Bahasa Indonesia
Español
हिन्दी
Filippiiniläinen
Français
Deutsch
Português
Türkçe
한국어
العربية
Abstract:IT giant Infosys reported its numbers for Q1 FY22 on Wednesday. Revenue came in at Rs 27,896 crore, up from Rs 26,311 crore in Q4 FY21. Net profit came in at Rs 5,195 crore, up 2.34% from Rs 5,076 crore in Q4 FY21.
IT giant Infosys Ltd (NS:INFY) reported its numbers for Q1 FY22 on Wednesday. Revenue came in at Rs 27,896 crore, up from Rs 26,311 crore in Q4 FY21. Net profit came in at Rs 5,195 crore, up 2.34% from Rs 5,076 crore in Q4 FY21.
Revenue beat analysts estimates while net profit came in a little short. The company revised its guidance for FY22 to 14-16% from an earlier 12-14%.
Is the stock a good buy? Infosys is currently trading at Rs 1,584 as of this report. Yes, say brokerages. Credit Suisse (SIX:CSGN) has upgraded the target price to Rs 1,890. It said while profits were a little short, the upwards revenue guidance is positive.
CLSA has a target of Rs 1,900 on Infosys. It said, “Expected upgrade in FY22 revenue growth guidance indicates strength of demand drivers. While we cut FY22 EPS by 2 percent, FY23/24 EPS estimates remain broadly unchanged. The company remains preferred play on growing digital spending and market share gains. It is also part of our Indias focus buy list.”
Goldman Sachs (NYSE:GS) said, “We believe the company's strategy to capture demand at the cost of margin is an apt one. Post Q1, we increase our revenue growth forecasts but cut down margin forecast and cut EPS estimates by 2-3%. Reiterate buy given best-in-class digital capability and seamless management execution.” It has a target of Rs 1,781 on Infosys stock.
What do you think? Leave your comments in our group!
Group link - https://chat.whatsapp.com/DluDphA3WML1cHrZ6SLa3c
Participate in the weekly topic interaction to stand a chance of winning July giveaway gifts!
Disclaimer:
The views in this article only represent the author's personal views, and do not constitute investment advice on this platform. This platform does not guarantee the accuracy, completeness and timeliness of the information in the article, and will not be liable for any loss caused by the use of or reliance on the information in the article.